Literature DB >> 3139003

High-affinity interleukin-2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis.

P Emery1, N Wood, K Gentry, A Stockman, I R Mackay, O Bernard.   

Abstract

The expression of receptors for interleukin-2 (IL-2R) was examined in patients with active or inactive rheumatoid arthritis (RA) and in control subjects. Unstimulated blood lymphocytes from patients with active RA had increased levels of total IL-2R, as measured by Tac-positive cells, compared with the levels found in the other 2 groups. Mitogen-stimulated cells from patients with active RA expressed less IL-2R per cell, but the most striking feature was the failure to express high-affinity IL-2R. These changes could reflect persistent antigenic stimulation and explain the defective cell-mediated immunity in RA patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139003     DOI: 10.1002/art.1780310914

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D Maurer; T Felzmann; W Holter; P Petera; J Smolen; W Knapp
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.

Authors:  D A Fox; J A Millard; L Kan; W S Zeldes; W Davis; J Higgs; F Emmrich; R W Kinne
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  J Briolay; J Dechanet; D Blanchard; J Banchereau; P Miossec
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

5.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

6.  Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.

Authors:  A Crilly; R Madhok; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

7.  Abnormal T-cell function in patients with psoriatic arthritis: evidence for decreased interleukin 2 production.

Authors:  J G Fort; J B Smith; J L Abruzzo
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.

Authors:  S Matsubayashi; F Akasu; Y Kasuga; K Snow; E Keystone; R Volpé
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

9.  Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis.

Authors:  A Kuryliszyn-Moskal
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.